What does CUSIP 3622AW403 represent in this 13F holders report?

CUSIP 3622AW403 is the security identifier for GRI - GRI Bio, Inc. - Common stock, par value $0.0001 per share used to aggregate holder disclosures.

How many institutions held GRI - GRI Bio, Inc. - Common stock, par value $0.0001 per share in Q3 2025?

8 institutional investors reported GRI - GRI Bio, Inc. - Common stock, par value $0.0001 per share for Q3 2025. Use the holders table for investor-level position and value details.

GRI Bio, Inc. - Common stock, par value $0.0001 per share (GRI)

CUSIP: 3622AW403

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class: Equity / Common stock, par value $0.0001 per share
Shares outstanding: 10,989,570
Total 13F shares: 134,385
Share change: +114,749
Total reported value: $276,832
Price per share: $2.06
Number of holders: 8
Value change: +$236,163
Number of buys: 5
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP 3622AW403?
CUSIP 3622AW403 identifies GRI - GRI Bio, Inc. - Common stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2025
Previous quarter: Q2 2025

Recent filing periods for CUSIP 3622AW403:

Q4 2025 Q3 2025 Q2 2025 Q1 2025

Top shareholders of GRI - GRI Bio, Inc. - Common stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Albert Agro	3/4/5	Chief Medical Officer	— class O/S missing	172,189	$702,531	—	21 Apr 2023	3/4/5
Walter Marc Hertz	3/4/5	Chief Executive Officer, Director	— class O/S missing	103,067	$88,956	—	18 Sep 2025	3/4/5
Marella Thorell	3/4/5	Director	— class O/S missing	9,506	$38,784	—	13 Dec 2022	3/4/5
David Leslie Szekeres	3/4/5	Director	— class O/S missing	39,897	$35,613	—	18 Sep 2025	3/4/5
Leanne Kelly	3/4/5	Chief Financial Officer	— class O/S missing	43,222	$29,704	—	18 Sep 2025	3/4/5
Vipin Chaturvedi	3/4/5	Chief Scientific Officer	— class O/S missing	43,222	$29,704	—	18 Sep 2025	3/4/5
Camilla Simpson V	3/4/5	Director	— class O/S missing	23,605	$20,775	—	18 Sep 2025	3/4/5
David Charles Baker	3/4/5	Director	— class O/S missing	23,605	$20,775	—	18 Sep 2025	3/4/5
Roelof Rongen	3/4/5	Director	— class O/S missing	23,605	$20,775	—	18 Sep 2025	3/4/5
Ofir Levi	3/4/5	Director	— class O/S missing	30,000	$20,571	—	14 May 2021	3/4/5
UBS Group AG	13F	Company	0.14%	15,455	$19,937	—	30 Jun 2025	13F
Penny Toren	3/4/5	SVP, Regul Affairs & Prog Mgmt	— class O/S missing	25,000	$17,143	—	14 May 2021	3/4/5
Meenu Chhabra	3/4/5	Director	— class O/S missing	15,000	$10,286	—	23 Feb 2022	3/4/5
Joseph E. Payne	3/4/5	Director	— class O/S missing	7,500	$5,143	—	09 Jun 2022	3/4/5
Richard Ammer	3/4/5	Director	— class O/S missing	7,500	$5,143	—	09 Jun 2022	3/4/5
Tower Research Capital LLC (TRC)	13F	Company	0.03%	3,834	$4,946	—	30 Jun 2025	13F
BlackRock, Inc.	13F	Company	0%	211	$272	—	30 Jun 2025	13F
SBI Securities Co., Ltd.	13F	Company	0%	117	$151	—	30 Jun 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	19	$25	—	30 Jun 2025	13F

Institutional Holders of GRI Bio, Inc. - Common stock, par value $0.0001 per share (GRI) as of Q3 2025

As of 30 Sep 2025, GRI Bio, Inc. - Common stock, par value $0.0001 per share (GRI) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 134,385 shares. The largest 8 holders included DRW Securities, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Tower Research Capital LLC (TRC), BlackRock, Inc., SBI Securities Co., Ltd., UBS Group AG, and BANK OF AMERICA CORP /DE/. This page lists 8 institutional shareholders reporting positions in this security for the Q3 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders

Q3 2025 holders

Holder diff

Investor	Q2 2025 Shares	Q3 2025 Shares	Share Diff	Share Chg %	Q2 2025 Value $	Q3 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.